These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mammalian alanine/glyoxylate aminotransferase 1 is imported into peroxisomes via the PTS1 translocation pathway. Increased degeneracy and context specificity of the mammalian PTS1 motif and implications for the peroxisome-to-mitochondrion mistargeting of AGT in primary hyperoxaluria type 1. Motley A; Lumb MJ; Oatey PB; Jennings PR; De Zoysa PA; Wanders RJ; Tabak HF; Danpure CJ J Cell Biol; 1995 Oct; 131(1):95-109. PubMed ID: 7559790 [TBL] [Abstract][Full Text] [Related]
4. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1. Danpure CJ J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801 [TBL] [Abstract][Full Text] [Related]
5. Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. Purdue PE; Takada Y; Danpure CJ J Cell Biol; 1990 Dec; 111(6 Pt 1):2341-51. PubMed ID: 1703535 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1. Leiper JM; Oatey PB; Danpure CJ J Cell Biol; 1996 Nov; 135(4):939-51. PubMed ID: 8922378 [TBL] [Abstract][Full Text] [Related]
7. A unique molecular basis for enzyme mistargeting in primary hyperoxaluria type 1. Leiper JM; Danpure CJ Clin Chim Acta; 1997 Oct; 266(1):39-50. PubMed ID: 9435987 [TBL] [Abstract][Full Text] [Related]
8. Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase. Danpure CJ Biochimie; 1993; 75(3-4):309-15. PubMed ID: 8507692 [TBL] [Abstract][Full Text] [Related]
9. A glycine-to-glutamate substitution abolishes alanine:glyoxylate aminotransferase catalytic activity in a subset of patients with primary hyperoxaluria type 1. Purdue PE; Lumb MJ; Allsop J; Minatogawa Y; Danpure CJ Genomics; 1992 May; 13(1):215-8. PubMed ID: 1349575 [TBL] [Abstract][Full Text] [Related]
10. Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation. Purdue PE; Allsop J; Isaya G; Rosenberg LE; Danpure CJ Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10900-4. PubMed ID: 1961759 [TBL] [Abstract][Full Text] [Related]
11. Effect of N-terminal alpha-helix formation on the dimerization and intracellular targeting of alanine:glyoxylate aminotransferase. Lumb MJ; Drake AF; Danpure CJ J Biol Chem; 1999 Jul; 274(29):20587-96. PubMed ID: 10400689 [TBL] [Abstract][Full Text] [Related]
12. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations. Lumb MJ; Danpure CJ J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483 [TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type 1. Cooper PJ; Danpure CJ; Wise PJ; Guttridge KM J Histochem Cytochem; 1988 Oct; 36(10):1285-94. PubMed ID: 3418107 [TBL] [Abstract][Full Text] [Related]
14. Molecular and clinical heterogeneity in primary hyperoxaluria type 1. Danpure CJ Am J Kidney Dis; 1991 Apr; 17(4):366-9. PubMed ID: 2008900 [TBL] [Abstract][Full Text] [Related]
15. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways. Danpure CJ Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096 [TBL] [Abstract][Full Text] [Related]
16. An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria. Danpure CJ; Cooper PJ; Wise PJ; Jennings PR J Cell Biol; 1989 Apr; 108(4):1345-52. PubMed ID: 2925788 [TBL] [Abstract][Full Text] [Related]
17. Alanine glyoxylate aminotransferase deficiency: biochemical and molecular genetic lessons from the study of a human disease. Watts RW Adv Enzyme Regul; 1992; 32():309-27. PubMed ID: 1496924 [TBL] [Abstract][Full Text] [Related]
18. ATP-dependent degradation of a mutant serine: pyruvate/alanine:glyoxylate aminotransferase in a primary hyperoxaluria type 1 case. Nishiyama K; Funai T; Yokota S; Ichiyama A J Cell Biol; 1993 Dec; 123(5):1237-48. PubMed ID: 8245128 [TBL] [Abstract][Full Text] [Related]
19. Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro. Lumb MJ; Birdsey GM; Danpure CJ Biochem J; 2003 Aug; 374(Pt 1):79-87. PubMed ID: 12737622 [TBL] [Abstract][Full Text] [Related]
20. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase. Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]